Gradient biomimetic platforms for neurogenesis studies

• Published in: Journal of neural engineering 2022-02, Vol.19 (1), p.11001
• Main Authors: Havins, Laurissa, Capel, Andrew, Christie, Steve, Lewis, Mark, Roach, P
• Format: Article
• Language: English
• Subjects: biomaterials; Biomimetics; Cell Culture Techniques - methods; Cell Differentiation; gradient; materials; neural engineering; neurogenesis; Neurogenesis - physiology; Reproducibility of Results; stem cells
• ISSN: 1741-2560; 1741-2552
• DOI: 10.1088/1741-2552/ac4639

There is a need for the development of new cellular therapies for the treatment of many diseases, with the central nervous system (CNS) currently an area of specific focus. Due to the complexity and delicacy of its biology, there is currently a limited understanding of neurogenesis and consequently a lack of reliable test platforms, resulting in several CNS based diseases having no cure. The ability to differentiate pluripotent stem cells into specific neuronal sub-types may enable scalable manufacture for clinical therapies, with a focus also on the purity and quality of the cell population. This focus is targeted towards an urgent need for the diseases that currently have no cure, e.g. Parkinson's disease. Differentiation studies carried out using traditional 2D cell culture techniques are designed using biological signals and morphogens known to be important for neurogenesis However, such studies are limited by their simplistic nature, including a general poor efficiency and reproducibility, high reagent costs and an inability to scale-up the process to a manufacture-wide design for clinical use. Biomimetic approaches to recapitulate a more like environment are progressing rapidly within this field, with application of bio(chemical) gradients presented both as 2D surfaces and within a 3D volume. This review focusses on the development and application of these advanced extracellular environments particularly for the neural niche. We emphasise the progress that has been made specifically in the area of stem cell derived neuronal differentiation. Increasing developments in biomaterial approaches to manufacture stem cells will enable the improvement of differentiation protocols, enhancing the efficiency and repeatability of the process with a move towards up-scaling. Progress in this area brings these techniques closer to enabling the development of therapies for the clinic.